Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Rebekah Harper
Rebekah Harper
Stock Analyst
(n/a)
# 4,531
Out of 4,534 analysts
4
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General
2 Stocks
Stock
Action
Price Target
Current
Upside
Ratings
Updated
NVS
Novartis AG
Upgrades:
Neutral
n/a
$118.56
-
3
May 25, 2018
AZN
AstraZeneca
Upgrades:
Neutral
n/a
$86.66
-
1
May 15, 2017
NVS
Novartis AG
May 25, 2018
Upgrades:
Neutral
Price Target:
n/a
Current: $118.56
Upside: -
3 Ratings
View All
AZN
AstraZeneca
May 15, 2017
Upgrades:
Neutral
Price Target:
n/a
Current: $86.66
Upside: -
1 Ratings
View All